XEGLYZE Drug Patent Profile
✉ Email this page to a colleague
When do Xeglyze patents expire, and what generic alternatives are available?
Xeglyze is a drug marketed by Hatchtech and is included in one NDA. There are five patents protecting this drug.
This drug has thirty-six patent family members in fifteen countries.
The generic ingredient in XEGLYZE is abametapir. One supplier is listed for this compound. Additional details are available on the abametapir profile page.
DrugPatentWatch® Generic Entry Outlook for Xeglyze
Xeglyze was eligible for patent challenges on July 31, 2024.
By analyzing the patents and regulatory protections it appears that the earliest date
for generic entry will be December 17, 2034. This may change due to patent challenges or generic licensing.
Indicators of Generic Entry
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for XEGLYZE?
- What are the global sales for XEGLYZE?
- What is Average Wholesale Price for XEGLYZE?
Summary for XEGLYZE
International Patents: | 36 |
US Patents: | 5 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 112 |
Patent Applications: | 290 |
What excipients (inactive ingredients) are in XEGLYZE? | XEGLYZE excipients list |
DailyMed Link: | XEGLYZE at DailyMed |

DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for XEGLYZE
Generic Entry Date for XEGLYZE*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
LOTION;TOPICAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
US Patents and Regulatory Information for XEGLYZE
XEGLYZE is protected by five US patents and one FDA Regulatory Exclusivity.
Based on analysis by DrugPatentWatch, the earliest date for a generic version of XEGLYZE is ⤷ Try for Free.
This potential generic entry date is based on patent 10,292,389.
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hatchtech | XEGLYZE | abametapir | LOTION;TOPICAL | 206966-001 | Jul 24, 2020 | DISCN | Yes | No | 7,812,163 | ⤷ Try for Free | Y | ⤷ Try for Free | |||
Hatchtech | XEGLYZE | abametapir | LOTION;TOPICAL | 206966-001 | Jul 24, 2020 | DISCN | Yes | No | 10,292,389 | ⤷ Try for Free | Y | ⤷ Try for Free | |||
Hatchtech | XEGLYZE | abametapir | LOTION;TOPICAL | 206966-001 | Jul 24, 2020 | DISCN | Yes | No | 9,839,631 | ⤷ Try for Free | Y | Y | ⤷ Try for Free | ||
Hatchtech | XEGLYZE | abametapir | LOTION;TOPICAL | 206966-001 | Jul 24, 2020 | DISCN | Yes | No | 8,212,038 | ⤷ Try for Free | Y | ⤷ Try for Free | |||
Hatchtech | XEGLYZE | abametapir | LOTION;TOPICAL | 206966-001 | Jul 24, 2020 | DISCN | Yes | No | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | ||||
Hatchtech | XEGLYZE | abametapir | LOTION;TOPICAL | 206966-001 | Jul 24, 2020 | DISCN | Yes | No | 9,357,783 | ⤷ Try for Free | Y | ⤷ Try for Free | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for XEGLYZE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Hatchtech | XEGLYZE | abametapir | LOTION;TOPICAL | 206966-001 | Jul 24, 2020 | 8,212,038 | ⤷ Try for Free |
Hatchtech | XEGLYZE | abametapir | LOTION;TOPICAL | 206966-001 | Jul 24, 2020 | 9,357,783 | ⤷ Try for Free |
Hatchtech | XEGLYZE | abametapir | LOTION;TOPICAL | 206966-001 | Jul 24, 2020 | 9,839,631 | ⤷ Try for Free |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for XEGLYZE
When does loss-of-exclusivity occur for XEGLYZE?
Based on analysis by DrugPatentWatch, the following patents block generic entry in the countries listed below:
Australia
Patent: 14377875
Patent: Pediculicidal composition
Estimated Expiration: ⤷ Try for Free
Canada
Patent: 33081
Patent: COMPOSITION PEDICULICIDE (PEDICULICIDAL COMPOSITION)
Estimated Expiration: ⤷ Try for Free
Eurasian Patent Organization
Patent: 1732
Patent: ПЕДИКУЛИЦИДНАЯ КОМПОЗИЦИЯ (PEDICULICIDAL COMPOSITION)
Estimated Expiration: ⤷ Try for Free
Patent: 1691033
Patent: ПЕДИКУЛИЦИДНАЯ КОМПОЗИЦИЯ
Estimated Expiration: ⤷ Try for Free
European Patent Office
Patent: 82424
Patent: COMPOSITION PEDICULICIDE (PEDICULICIDAL COMPOSITION)
Estimated Expiration: ⤷ Try for Free
Japan
Patent: 11751
Estimated Expiration: ⤷ Try for Free
Patent: 17500342
Patent: シラミ駆除組成物
Estimated Expiration: ⤷ Try for Free
New Zealand
Patent: 0995
Patent: Pediculicidal composition
Estimated Expiration: ⤷ Try for Free
Spain
Patent: 67618
Estimated Expiration: ⤷ Try for Free
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
See the table below for additional patents covering XEGLYZE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Spain | 2483800 | ⤷ Try for Free | |
China | 1822854 | Methods and compositions for controlling ectoparasites | ⤷ Try for Free |
Brazil | PI0412544 | métodos de inibição de eclosão de ovo de um ectoparasito, de tratamento ou prevenção de infestação por ectoparasito em hospedeiro e de identificação de composto inibidor da eclosão de ovo de ectoparasito, respectivas composições e usos de agente quelante de metal e de pelo menos um inibidor de metaloprotease | ⤷ Try for Free |
China | 100593419 | ⤷ Try for Free | |
Japan | 2017500342 | シラミ駆除組成物 | ⤷ Try for Free |
Canada | 2595468 | PROCEDES ET COMPOSITIONS SERVANT A LUTTER CONTRE DES ECTOPARASITES (METHODS AND COMPOSITIONS FOR CONTROLLING ECTOPARASITES) | ⤷ Try for Free |
World Intellectual Property Organization (WIPO) | 2015107384 | ⤷ Try for Free | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Market Dynamics and Financial Trajectory for Xeglyze
More… ↓